How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Sequencing Kit Market
- By Sequencing Technology: Illumina Sequencing Kits, Ion Torrent Sequencing Kits, Pacific Biosciences (PacBio) Sequencing Kits, Oxford Nanopore Sequencing Kits, BGI/MGI Sequencing Kits
- By Application: Whole Genome Sequencing Kits, Targeted Sequencing Kits, RNA Sequencing Kits, Epigenetic Sequencing Kits, Metagenomic Sequencing Kits
- By End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Clinical and Diagnostic Laboratories, Agricultural and Environmental Research Centers, Contract Research Organizations (CROs)
- By Kit Format: Library Preparation Kits, Sequencing Reagent Kits, Sample Preparation Kits, Enrichment Kits, Barcoding and Indexing Kits
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Illumina Sequencing Kits leads By Sequencing Technology at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Sequencing Kit Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Sequencing Technology 5
Application 5
End User 5
Kit Format 5
Companies profiled
Illumina Inc.
Thermo Fisher Scientific Inc.
Pacific Biosciences of California Inc.
Oxford Nanopore Technologies Ltd.
QIAGEN N.V.
BGI Genomics Co. Ltd.
Roche Sequencing Solutions (Roche Holding AG)
Agilent Technologies Inc.
PerkinElmer Inc.
Takara Bio Inc.
New England Biolabs Inc.
Bio-Rad Laboratories Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Illumina Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Pacific Biosciences of California Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Oxford Nanopore Technologies Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →QIAGEN N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BGI Genomics Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Roche Sequencing Solutions (Roche Holding AG)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Agilent Technologies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →PerkinElmer Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Takara Bio Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →New England Biolabs Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bio-Rad Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Integrated DNA Technologies Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Lexogen GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Twist Bioscience Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$9,216M by 2033 · 9.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Illumina Sequencing Kits50.2
- Ion Torrent Sequencing Kits13.3
- Pacific Biosciences (PacBio) Sequencing Kits16.5
- Oxford Nanopore Sequencing Kits10.6
- BGI/MGI Sequencing Kits9.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,492M → $2,894M · 8.6%
Europe$1,040M → $2,366M · 10.8%
Asia Pacific$949.2M → $1,742M · 7.9%
Latin America$587.6M → $1,160M · 8.9%
Middle East and Africa$452.0M → $914.2M · 9.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.262026
9.282027
9.292028
9.312029
9.312030
9.332031
9.332032
9.362033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Illumina Inc.15.7
- Thermo Fisher Scientific Inc.18.0
- Pacific Biosciences of California Inc.7.9
- Oxford Nanopore Technologies Ltd.8.2
- QIAGEN N.V.13.3
- BGI Genomics Co. Ltd.8.8
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Sequencing Technology31.1%
Application17.8%
End User15.3%
Kit Format35.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.9
- Europe26.1
- Asia Pacific19.2
- Latin America12.8
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Illumina Inc. | 86 | 88 | 86 | 87 | 86 | 83 | 86 |
| Thermo Fisher Scientific Inc. | 71 | 89 | 87 | 81 | 84 | 68 | 80 |
| Pacific Biosciences of California Inc. | 68 | 79 | 80 | 74 | 71 | 81 | 76 |
| Oxford Nanopore Technologies Ltd. | 63 | 76 | 72 | 59 | 67 | 76 | 69 |
| QIAGEN N.V. | 64 | 72 | 65 | 75 | 68 | 74 | 70 |
| BGI Genomics Co. Ltd. | 53 | 59 | 65 | 65 | 53 | 53 | 58 |
| Roche Sequencing Solutions (Roche Holding AG) | 48 | 41 | 61 | 57 | 50 | 42 | 50 |
| Agilent Technologies Inc. | 46 | 56 | 53 | 42 | 44 | 52 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Illumina Inc.
- Thermo Fisher Scientific Inc.
- Pacific Biosciences of California Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Illumina Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Thermo Fisher Scientific Inc. | ◐ | ✓ | ◐ | ◐ | ◐ | ◐ |
| Pacific Biosciences of California Inc. | − | ◐ | ✓ | ✓ | ◐ | ◐ |
| Oxford Nanopore Technologies Ltd. | ◐ | ✓ | ◐ | ◐ | ◐ | ✓ |
| QIAGEN N.V. | ◐ | ✓ | − | ◐ | − | − |
| BGI Genomics Co. Ltd. | ◐ | ◐ | − | ✓ | − | ◐ |
| Roche Sequencing Solutions (Roche Holding AG) | − | − | ◐ | ◐ | − | − |
| Agilent Technologies Inc. | − | ◐ | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Illumina Inc.86
2Thermo Fisher Scientific Inc.80
3Pacific Biosciences of California Inc.76
4QIAGEN N.V.70
5Oxford Nanopore Technologies Ltd.69
6BGI Genomics Co. Ltd.58
7Roche Sequencing Solutions (Roche Holding AG)50
8Agilent Technologies Inc.49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Illumina Inc.Thermo Fisher Scientific Inc.
Challenger3
Strong scale, closing on the leaders.
Pacific Biosciences of California Inc.Oxford Nanopore Technologies Ltd.QIAGEN N.V.
Contender1
Focused players with pockets of strength.
BGI Genomics Co. Ltd.
Niche2
Specialists in a single segment or region.
Roche Sequencing Solutions (Roche Holding AG)Agilent Technologies Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Sequencing Technology in North America, then scale across Sequencing Kit Market — a $442M beachhead inside a $6.98B market.
Beachhead (SOM)$442Mobtainable near-term
Serviceable (SAM)$2.40Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Illumina Sequencing Kits
Best fit — highest urgency & budget in Sequencing Technology.
Economic buyer80 fit
Ion Torrent Sequencing Kits
Strong fit — clear ROI and a fast path to value.
End user69 fit
Pacific Biosciences (PacBio) Sequencing Kits
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Sequencing Technology in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel26%
Digital / self-serve21%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Sequencing Technology leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Sequencing Kit Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified22%
Evaluation13%
Closed-won8%
$9.3KCAC
$38KLTV
4.0:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Sequencing Kit Market is a durable-growth opportunity — $10.3B by 2033, compounding at 9.3%.
TAM · 2025$5.07Btoday
TAM · 2033$10.3Bforecast
CAGR9.3%2027–2033
Cumulative$66.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.3BTotal addressable market
SAM$3.76BServiceable available market
SOM$728MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.3% CAGR
Demand compounds through 2033, outpacing GDP across Sequencing Technology.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Sequencing Technology moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.3BLarge & growingTAM by 2033 at 9.3% CAGR
$3.76BServiceable nowreachable with today’s model
$728MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$8.04BBear6.0% CAGR
$10.3BBase9.3% CAGR
$13.2BBull12.2% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Sequencing Kit Market — a $5.46B market by 2033. Plan: grow share from 9.0% to 14.6%.
Market size · 2033$5.46Btotal addressable
Market CAGR3.3%2027–2033
Target share14.6%from 9.0% today
Revenue ambition$797Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.0% | 14.6% | On track |
| Revenue | $507M | $797M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 31.4% | 39.8% | At risk |
| Customer retention | 89.7% | 95.6% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Sequencing Technology
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Sequencing Technology share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $87M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Sequencing Technology leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Sequencing Kit Market conversation — a $4.17B market you can size, segment and defend in minutes.
Market size · 2033$4.17Btotal opportunity
Growth4.2%CAGR to 2033
Addressable buyers1,260+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Sequencing Technology
Goal Grow share in Sequencing Technology
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 3 mopayback period
$44K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Illumina Inc.Thermo Fisher Scientific Inc.Pacific Biosciences of California Inc.Oxford Nanopore Technologies Ltd.QIAGEN N.V.BGI Genomics Co. Ltd.Roche Sequencing Solutions (Roche Holding AG)Agilent Technologies Inc.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Sequencing Kit Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Sequencing Kit Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Sequencing Gene Analyzer Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportSeptum-Type Infusion Connector Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportSeptum Cap Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportSeptoplasty Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSeptin 9 Methylated Colorectal Cancer Detection Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportSeptic Shock Therapy Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportSeptic Shock Therapeutics Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportSepticemia Diagnostic Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportSeptal Occluders Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSeptal Defect Occluder Market
Market size, share, segmentation and regional forecast.
$381M market · 2025 base year
View reportSEPT9 Methylation Detection Kit Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportSEPT7 Antibody Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.